Brief: KalVista Pharma to Present Phase 3 Sebetralstat Data
Feb 16 (Reuters) - Kalvista Pharmaceuticals Inc
KALV.O :
* KALVISTA PHARMACEUTICALS TO PRESENT PHASE 3 SEBETRALSTAT
DATA AT
THE 2024 AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY ANNUAL
MEETING
* KALVISTA PHARMACEUTICALS INC - LATE-BREAKING PHASE 3 DATA
FOR
KONFIDENT TRIAL ON SUNDAY, FEBRUARY 25, 2024
Source text for Eikon: ID:nBwbd87Dva
Further company coverage: KALV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy